Skip to main content

Fisher Asset Management, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 850529 PLANO, TX

Position in NBIX

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$22,770,428
+$6,668,375 QoQ
Shares Held
135,104
+10.5% QoQ
Ownership
0.133%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#103
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 77% Shared 0% None 23%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Fisher Asset Management, LLC holds $131,969,402 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (17.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
135,104 $22,770,428

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,770,428 135,104
2026-03-31 $16,102,053 122,226
2025-12-31 $15,919,282 112,242
2025-09-30 $13,307,322 94,795
2025-06-30 $11,002,902 87,540
2025-03-31 $10,535,424 95,257
2024-12-31 $12,572,196 92,104
2024-09-30 $7,866,069 68,270
2024-06-30 $8,720,017 63,340
2024-03-31 $8,987,694 65,166
2023-12-31 $7,935,509 60,227
2023-09-30 $6,955,537 61,827
2023-06-30 $5,847,165 62,006
2023-03-31 $6,492,453 64,142
2022-12-31 $7,676,169 64,268
2022-09-30 $6,915,970 65,116
2022-06-30 $6,870,195 70,478
2022-03-31 $6,999,000 74,656
2021-12-31 $6,357,684 74,647
2021-09-30 $6,636,396 69,194
2021-06-30 $5,999,680 61,649
2021-03-31 $5,657,616 58,176
2020-12-31 $5,504,665 57,430
2020-09-30 $5,694,691 59,221
2020-06-30 $7,713,694 63,227
2020-03-31 $5,588,273 64,567